Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA Approves New Schizophrenia Drug in 70-Year 1st
New schizophrenia drug gets FDA approval, taking novel approach to treating brain disorder
On Thursday, the U.S. Food and Drug Administration approved COBENFY, an oral medication that marks the first new class of drugs for schizophrenia in more than 30 years.
FDA Approves the First New Schizophrenia Drug in Decades
Developed by Karuna Therapeutics, which was subsequently acquired by Bristol Myers Squibb, the drug works in an entirely different way from existing medications for schizophrenia, which is building excitement and enthusiasm among doctors and patients alike.
FDA approves 1st new drug for schizophrenia in more than 30 years
The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with schizophrenia in more than 30 years.
KALW
4h
A new kind of drug for schizophrenia promises fewer side effects
A medicine that sidesteps the brain's dopamine receptors to reach different targets represents a new approach to ...
17h
FDA Approves New Schizophrenia Drug in 70-Year First
The treatment offers hope to thousands of patients who do not respond to existing medications, and has shown promise in treating other neurological disorders.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
'Harry Potter' star dies
Helene: How to help
High-end brothel plea
Troops to leave some bases
Promotes watch collection
ICE: Convicts roaming free
World's oldest cheese found
50/50 ball ownership suit
Killer gets life sentence
Producing doc on Diddy
Diocese reaches settlement
Boxes to distribute Narcan
KY sues Express Scripts
Ending password-sharing
Fake Biden robocalls fine
Urgent safety alert for 737s
Pleads not guilty
US charges three Iranians
ISR targets Hezbollah HQ
NC dam failure ‘imminent’
Fed inflation gauge cools
Meta hit with privacy fine
Bill to use birth control
Van Gogh paintings attacked
NY ballot appeal rejected
Deposition in AI suit
Dow closes at record high
Haney sues Garcia
Feedback